Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss without scarring is more common than permanent hair loss with scarring, and is often due to genetic factors.

A woman's temporary hair loss was caused by high prolactin levels from her medication.

Telogen effluvium is a common, distressing condition causing excessive hair shedding and has significant psychological effects on patients.

The poem reflects on hair loss, health concerns, and introspection.

A scalp biopsy can help confirm hair loss types when other methods don't provide a clear diagnosis.

Early treatment is important for better hair regrowth in elderly women with hair loss.

The poem ends by asking for case reports on serious health issues like Telogen Effluvium.

The trichotillometer is a simple, effective tool for diagnosing and assessing female pattern hair loss.

Hair loss in rural Indian children is often due to malnutrition, poor grooming, stress, and infections.

Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.

Most patients with chronic hair shedding did not progress to permanent hair loss, and one showed improvement with treatment.

People with Chronic Telogen Effluvium mainly have lower iron levels compared to healthy individuals.

The supplement improved hair growth and reduced hair loss in women.

The belief about hair shedding phases is likely incorrect and needs reevaluation.

Reassurance and counseling are key in managing acute telogen effluvium, with supplements possibly offering a placebo effect.

Polynucleotide gel injections help reduce hair loss and increase hair thickness in people with pattern hair loss, with few side effects.

Low iron, low thyroid function, and stress are linked to excessive hair shedding in women.

Low zinc levels are strongly linked to hair loss in adult premenopausal women.

Androgens affect hair growth and shedding, with genetic and non-genetic factors influencing baldness.

Oral minoxidil effectively reduces hair shedding in women with chronic telogen effluvium.

Oral minoxidil significantly reduces hair shedding in women with chronic telogen effluvium.

The document concludes that a man's long hair may have helped diagnose his rare case of chronic hair shedding, for which no treatment is advised.

Low-dose oral minoxidil is a promising, safe treatment for various hair diseases, improving hair thickness and density, but more research is needed on long-term side effects and treatment duration.

Cudrania tricuspidata and Sargassum fusiforme extracts improved hair growth in mice by affecting growth-related genes.

Hair is thinner near the scalp in acute hair shedding conditions.

Hair loss in a drug reaction case involved both a common shedding phase and an immune attack on hair follicle stem cells.

Low iron levels are linked to more hair loss in women with chronic hair shedding.

Most lab tests for patients with Telogen effluvium, a type of hair loss, show no or mild abnormalities; only a few specific tests are useful.

The condition called 'acute diffuse and total alopecia of the female scalp' is actually a known condition named alopecia areata incognita.

The study concluded that neonatal occipital alopecia is common, not caused by physical friction, and usually resolves on its own without treatment.